These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 12009707)
1. A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies. Zhang F; Fath M; Marks R; Linhardt RJ Anal Biochem; 2002 May; 304(2):271-3. PubMed ID: 12009707 [No Abstract] [Full Text] [Related]
2. Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop. Nakajima H; Cocquerel L; Kiyokawa N; Fujimoto J; Levy S Biochem Biophys Res Commun; 2005 Mar; 328(4):1091-100. PubMed ID: 15707989 [TBL] [Abstract][Full Text] [Related]
3. Electrokinetic lab-on-a-biochip for multi-ligand/multi-analyte biosensing. Krishnamoorthy G; Carlen ET; deBoer HL; van den Berg A; Schasfoort RB Anal Chem; 2010 May; 82(10):4145-50. PubMed ID: 20402468 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides. Liu L; Bytheway I; Karoli T; Fairweather JK; Cochran S; Li C; Ferro V Bioorg Med Chem Lett; 2008 Jan; 18(1):344-9. PubMed ID: 17981035 [TBL] [Abstract][Full Text] [Related]
5. An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2. Cochran S; Li CP; Bytheway I Chembiochem; 2005 Oct; 6(10):1882-90. PubMed ID: 16175541 [TBL] [Abstract][Full Text] [Related]
6. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857 [TBL] [Abstract][Full Text] [Related]
7. The oligomeric structure of vaccinia viral envelope protein A27L is essential for binding to heparin and heparan sulfates on cell surfaces: a structural and functional approach using site-specific mutagenesis. Ho Y; Hsiao JC; Yang MH; Chung CS; Peng YC; Lin TH; Chang W; Tzou DL J Mol Biol; 2005 Jun; 349(5):1060-71. PubMed ID: 15913650 [TBL] [Abstract][Full Text] [Related]
8. Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors. Marks RM; Lu H; Sundaresan R; Toida T; Suzuki A; Imanari T; Hernáiz MJ; Linhardt RJ J Med Chem; 2001 Jun; 44(13):2178-87. PubMed ID: 11405655 [TBL] [Abstract][Full Text] [Related]
9. Interaction analysis of viral cytokine-binding proteins using surface plasmon resonance. Seet BT; McFadden G Methods Mol Biol; 2004; 269():219-42. PubMed ID: 15114019 [TBL] [Abstract][Full Text] [Related]
11. Microarrays of heparin oligosaccharides obtained by nitrous acid depolymerization of isolated heparin. de Paz JL; Spillmann D; Seeberger PH Chem Commun (Camb); 2006 Aug; (29):3116-8. PubMed ID: 16855704 [TBL] [Abstract][Full Text] [Related]
12. Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide. Canales A; Angulo J; Ojeda R; Bruix M; Fayos R; Lozano R; Giménez-Gallego G; Martín-Lomas M; Nieto PM; Jiménez-Barbero J J Am Chem Soc; 2005 Apr; 127(16):5778-9. PubMed ID: 15839662 [TBL] [Abstract][Full Text] [Related]
13. Dynamics of complex formation between biological and luminescent conjugated polyelectrolytes--a surface plasmon resonance study. Björk P; Persson NK; Peter K; Nilsson R; Asberg P; Inganäs O Biosens Bioelectron; 2005 Mar; 20(9):1764-71. PubMed ID: 15681192 [TBL] [Abstract][Full Text] [Related]
14. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054 [TBL] [Abstract][Full Text] [Related]
15. Immobilization and clustering of structurally defined oligosaccharides for sugar chips: an improved method for surface plasmon resonance analysis of protein-carbohydrate interactions. Suda Y; Arano A; Fukui Y; Koshida S; Wakao M; Nishimura T; Kusumoto S; Sobel M Bioconjug Chem; 2006; 17(5):1125-35. PubMed ID: 16984119 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells. Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056 [TBL] [Abstract][Full Text] [Related]
17. Identification of glycosaminoglycan-binding sites within hepatitis C virus envelope glycoprotein E2*. Olenina LV; Kuzmina TI; Sobolev BN; Kuraeva TE; Kolesanova EF; Archakov AI J Viral Hepat; 2005 Nov; 12(6):584-93. PubMed ID: 16255759 [TBL] [Abstract][Full Text] [Related]
18. Biosensors for RNA aptamers-protein interaction. Tombelli S; Minunni M; Mascini M Methods Mol Biol; 2008; 419():109-19. PubMed ID: 18369978 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the interaction between the envelope protein domains and the core protein of human hepatitis B virus. Choi KJ; Lim CW; Yoon MY; Ahn BY; Yu YG Biochem Biophys Res Commun; 2004 Jul; 319(3):959-66. PubMed ID: 15184075 [TBL] [Abstract][Full Text] [Related]